Biotech Growth N V - Oct 17, 2023 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/ Ivo Betschart
Stock symbol: BDTX
Transactions as of: Oct 17, 2023
Transactions value $: $934,080
Form type: 4
Date filed: 10/19/2023, 03:08 PM
Previous filing: Jul 3, 2023
Next filing: Nov 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$934K	+400K	+4.93%	$2.34	8.52M	Oct 17, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.